Jiangsu Hengrui Pharmaceuticals Co.,Ltd (SHA:600276)

SHA:600276 Revenue

Jiangsu Hengrui Pharmaceuticals Co.,Ltd had revenue of 8.14B CNY in the quarter ending March 31, 2026, with 12.98% growth. This brings the company's revenue in the last twelve months to 32.56B, up 11.55% year-over-year. In the year 2025, Jiangsu Hengrui Pharmaceuticals Co.,Ltd had annual revenue of 31.63B with 13.02% growth.

• Revenue (ttm): 32.56B
• Revenue Growth: +11.55%
• P/S Ratio: 10.57
• Revenue / Employee: 1.58M
• Employees: 20,602
• Market Cap: 344.06B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	31.63B	3.64B	13.02%
Dec 31, 2024	27.98B	5.16B	22.63%
Dec 31, 2023	22.82B	1.54B	7.26%
Dec 31, 2022	21.28B	-4.63B	-17.87%
Dec 31, 2021	25.91B	-1.83B	-6.59%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 29, 2026

Data Sources Report a data error